Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
An extensive study by Hanigan et al
DSIP is investigated as a peptide signal that may fine-tune endogenous regulatory circuits
Current Pharmaceutical Design, 20(7), 11211125
The overarching material developed and investigated comprises AngIV-based compounds, designed to overcome the limitations of native peptides like AngIV, which suffer from poor metabolic stability and inability to cross the BBB due to their size and hydrophilicity
In adipose tissues, GIP but not GLP-1 facilitates fat deposition
US$ 21.28
US$ 24.79
US$ 26.56
US$ 27.91
US$ 22.70
US$ 25.06
